oral semaglutide versus subcutaneous semaglutide Will be a game-changer in the management of type 2 diabetes in primary care? Oral vs. Injectable Semaglutide: Rybelsus,

Thuc ch vn GLP-1 c th lm tng nguy c tro ngc v ht sc cc cht trong d dy vo phi trong qu trnh gy m ton thn v gy m su

Dosage & Administration Adults: 1 tablet twice daily after meals Continue for at least 3 months for fertility indications Take with water Side Effects Generally well tolerated Mild GI upset Fishy body odour (with high-dose L-carnitine) rare Allergic reaction (rare) Contraindications Hypersensitivity to L-Carnitine or CoQ10 Severe hypotension (CoQ10 may slightly lower BP) Children unless specialist advice Concurrent warfarin (CoQ10 may slightly reduce INR monitor) Storage Store below 30 C in a dry place, protected from light and moisture

8.3 Females and Males of Reproductive Potential Discontinue RYBELSUS in women at least 2 months before a planned pregnancy due to the long washout period for semaglutide [see Use in Specific Populations (8.1)]

The Precision Peptide Genetic Test may help provide context regarding individual predispositions in key peptide pathwaysincluding GIPR, GLP1R, FTO, and MC4R variantswhich can support a more informed provider conversation about treatment selection